Related references
Note: Only part of the references are listed.Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients
Giulia Siravegna et al.
MOLECULAR ONCOLOGY (2016)
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Mariangela Russo et al.
CANCER DISCOVERY (2016)
Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer Does the Seed Leave the Soil Again?
Nuh N. Rahbari et al.
ANNALS OF SURGERY (2016)
Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
Georgios A. Margonis et al.
CANCER (2016)
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
Francesco Passiglia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis
Minoru Koi et al.
GASTROENTEROLOGY (2016)
Deciphering the Molecular Code to Colorectal Liver Metastasis Biology Through Microsatellite Alterations and Allelic Loss: The Good, the Bad, and the Ugly
Kjetil Soreide et al.
GASTROENTEROLOGY (2016)
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
Kjetil Soreide et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection
Anita Sveen et al.
PLOS GENETICS (2016)
The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
Shiva Basnet et al.
JOURNAL OF CANCER (2016)
Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
Carlyn Rose C. Tan et al.
CURRENT COLORECTAL CANCER REPORTS (2016)
Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
Kristoffer Watten Brudvik et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
Z. S. Lalmahomed et al.
BRITISH JOURNAL OF CANCER (2015)
Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases
E. Simoneau et al.
BRITISH JOURNAL OF SURGERY (2015)
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
K. W. Brudvik et al.
BRITISH JOURNAL OF SURGERY (2015)
Should the Results of the New EPOC Trial Change Practice in the Management of Patients With Resectable Metastatic Colorectal Cancer Confined to the Liver?
Bernard Nordlinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Metastatic Colorectal Cancer: Current State and Future Directions
Marwan G. Fakih
JOURNAL OF CLINICAL ONCOLOGY (2015)
Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified?
Yoshihiro Mise et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Association between KRAS mutation and lung metastasis in advanced colorectal cancer
A. A. L. Pereira et al.
BRITISH JOURNAL OF CANCER (2015)
Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer
M. M. C. Watson et al.
BRITISH JOURNAL OF CANCER (2014)
KRAS Mutation in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis: A Biomarker of Cancer Biology or a Byproduct of Patient Selection?
Kjetil Soreide et al.
CANCER (2014)
KRAS Mutation Influences Recurrence Patterns in Patients Undergoing Hepatic Resection of Colorectal Metastases
Nancy E. Kemeny et al.
CANCER (2014)
Cetuximab for resectable colorectal liver metastasis: New EPOC trial
Kiyoshi Hasegawa et al.
LANCET ONCOLOGY (2014)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose et al.
LANCET ONCOLOGY (2014)
Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era
Dordi Lea et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer
B. S. Nedrebo et al.
BRITISH JOURNAL OF SURGERY (2011)
Urgent need for a new staging system in advanced colorectal cancer
Graeme J. Poston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Microsatellite instability in colorectal cancer
K Söreide et al.
BRITISH JOURNAL OF SURGERY (2006)
Share Paper
